While reporting financial results for the third quarter on Thursday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) slashed its earnings guidance for the full-year 2019, while raising full year adjusted earnings outlook.
from RTT - Earnings https://ift.tt/36hkLyt
via IFTTT
No comments:
Post a Comment